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RNA sequencing of chorionic villi 
from recurrent pregnancy loss 
patients reveals impaired  
function of basic nuclear and 
cellular machinery
Siim Sõber1,*, Kristiina Rull1,2,3,*, Mario Reiman1, Piret Ilisson4, Pirkko Mattila5,6 & Maris Laan1,7
Recurrent pregnancy loss (RPL) concerns ~3% of couples aiming at childbirth. In the current study, 
transcriptomes and miRNomes of 1st trimester placental chorionic villi were analysed for 2 RPL cases 
(≥6 miscarriages) and normal, but electively terminated pregnancies (ETP; n = 8). Sequencing was 
performed on Illumina HiSeq 2000 platform. Differential expression analyses detected 51 (27%) 
transcripts with increased and 138 (73%) with decreased expression in RPL compared to ETP (DESeq: 
FDR P < 0.1 and DESeq2: <0.05). RPL samples had substantially decreased transcript levels of 
histones, regulatory RNAs and genes involved in telomere, spliceosome, ribosomal, mitochondrial and 
intra-cellular signalling functions. Downregulated expression of HIST1H1B and HIST1H4A (Wilcoxon 
test, fc≤0.372, P≤9.37 × 10−4) was validated in an extended sample by quantitative PCR (RPL, n = 14; 
ETP, n = 24). Several upregulated genes are linked to placental function and pregnancy complications: 
ATF4, C3, PHLDA2, GPX4, ICAM1, SLC16A2. Analysis of the miRNA-Seq dataset identified no large 
disturbances in RPL samples. Notably, nearly 2/3 of differentially expressed genes have binding sites 
for E2F transcription factors, coordinating mammalian endocycle and placental development. For 
a conceptus destined to miscarriage, the E2F TF-family represents a potential key coordinator in 
reprogramming the placental genome towards gradually stopping the maintenance of basic nuclear  
and cellular functions.
Pregnancy loss, defined as an expulsion of the conceptus before 22 weeks of gestation, is the most common 
pregnancy complication. One in ten clinically confirmed pregnancies results in miscarriage. In fact, already prior 
to implantation stage ~30% of human conceptions are lost and another ~30% are detected only as ‘biochemical 
pregnancies’ (positive circulating hCG test), which fail to develop further1. Recurrent pregnancy loss (RPL)2, con-
cerning ~3% of couples aiming at childbirth, is generally defined as ≥ 2 or ≥ 3 consecutive pregnancy losses of a 
couple3–5. Whereas the majority of sporadic cases of pregnancy loss (~75%) are due to chromosomal aneuploidies 
arising from occasional non-inherited nondisjunction events, the known causes behind RPL include parental 
chromosomal aberrations, maternal thrombophilic and (auto) immune disorders, endocrine disturbances, uter-
ine abnormalities and infections1,2,6,7. Still, couples with idiopathic RPL without any clear cause represent 25–50% 
of all cases. A longitudinal study from the Danish Recurrent Pregnancy Loss Clinic showed that even after being 
referred to a specialized RPL clinic, 33% of the RPL couples remain childless after 5 years8. Epidemiological stud-
ies have revealed that a subsequent pregnancy after a series of miscarriages has an increased risk to preterm birth, 
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stillbirth, preeclampsia and fetal growth restriction9,10. Taken together – as RPL represents an unrecognized com-
mon disorder with immediate and long-term consequences on an entire family, there is an urgent need to uncover 
novel mechanisms behind its occurrence with the ultimate goal to utilize this knowledge in clinical management.
Capturing gene expression profiles and biological pathways involved in failed pregnancy may assist in pin-
pointing novel biomarkers or therapeutic targets potentially applicable in clinical conditions for the benefit of 
RPL patients. There are limited studies investigating transcriptome-wide gene expression signatures linked to 
the disturbances at the maternal-fetal interface, possibly contributing to abnormal placental development and/
or reflecting the biological mechanisms behind RPL. The two seminal studies using gene expression microar-
ray profiling of placental samples from RPL cases detected no differentially expressed genes with highly sig-
nificant statistical support. The first study detected 133 genes showing a trend (fold change (fc) > 2; nominal 
P-value < 0.05) for decreased and 22 genes for increased expression in the deciduas (maternal side of the pla-
centa) of RPL patients compared to uncomplicated pregnancy11. The study by our team identified only 27 genes 
(fc, 1.4 to 4.1; P-value < 0.05) with a trend for altered expression in the RPL placental tissue12. Both reports high-
lighted an enrichment of dysregulated genes involved in cell communication and signalling, inflammatory and 
immune response.
Compared to microarrays, RNA sequencing (RNA-Seq) provides substantially higher resolution to capture the 
entire transcriptome, capable for precise measurement of the level of all protein-coding and non-coding (ncRNA) 
transcripts. RNA-Seq has several other advantages, such as higher statistical power due to > 10–15 times wider 
dynamic range to quantify gene expression level compared to microarrays13. We have previously applied RNA-Seq 
to investigate placental differential gene expression signatures in prevalent adverse pregnancy outcomes at term14. 
The analysis convincingly showed that the placental transcriptome in late gestational complication preeclampsia 
is clearly distinct not only from normal pregnancy, but also from other common adverse pregnancy outcomes at 
term. The current study aimed to bring novel insights behind the molecular mechanisms and involved pathways 
leading to pregnancy loss. We utilized RNA-Seq and miRNA-Seq to profile the transcriptome of the first trimester 
placental chorionic villi in cases of RPL compared to normal, but electively terminated (ETP) pregnancies. Our 
data shows that in the placentas from RPL cases, the majority of differentially expressed genes are downregulated. 
These genes are explicitly involved in the basic machinery required for replication and chromatin integrity, tran-
scription and RNA processing, maintenance of mitochondria and other essential genome functions required in 
the process of rapid cellular proliferation and differentiation critical in early placental development. The identified 
genes with increased transcript levels confirmed several loci previously linked to placental malfunction in RPL 
pregnancies. Most importantly, a large fraction of differentially expressed genes in RPL possess binding sites for 
E2F transcription factors known to be involved in regulating the replication machinery of the mammalian end-
ocycle – a key process to guarantee normal trophoblast proliferation and invasion, placental development, and 
fetal viability.
Results
RNA-Seq dataset of first trimester chorionic villi from normal and RPL pregnancies. We per-
formed whole transcriptome (RNA-Seq) and miRNome (miRNA-Seq) sequencing for chorionic villi dissected 
from the placental samples representing first trimester human pregnancy. The study sample included two cases 
of recurrent pregnancy loss (RPL1, female fetus, fetal death at the 44th gestational day; RPL2, male, 67th g. d.) and 
a control group comprised of clinically normal, electively terminated pregnancies (ETP; n = 8; 3 male, 5 female 
fetuses; 51 to 81 g. d.) (Table 1). Before the event, the two RPL cases had experienced five and six clinically con-
firmed pregnancy losses, respectively. At the index pregnancy, the placental sampling was conducted along with 
the surgical removal of conceptus shortly after detection of fetal death (see Methods; Supplementary Methods).
Total RNA extracted from chorionic villous samples and depleted of ribosomal RNA was subjected to previ-
ously reported14 RNA-Seq pipeline providing 46-base pair (bp) paired-end reads (Illumina HiSeq 2000). After 
filtering the raw reads, the transcriptomes of analysed chorionic villous samples in the RPL samples yielded 
41.3 and 63.3 million paired-end reads (Supplementary Fig. S1a). Individual transcriptomes of the 8 ETP sam-
ples yielded on average 42.0 million paired-end reads (range: 28.1–48.2 million). The reads were aligned to the 
human genome with an average success rate of 85.2% (range: 80.2–91.5%; Supplementary Fig. S1b). The complete 
RNA-Seq dataset over the sequenced 1st trimester chorionic villous samples (n = 10) was comprised of 31.8 billion 
aligned bases and in total providing ~199 fold mean coverage over exonic regions (exonic coverage per sample: 
median 19.3, range 11.3–36.0 fold; Supplementary Fig. S1c,d). RNA-Seq datasets of all samples exhibited similar 
distribution and quantity of read counts (Supplementary Fig. S1f). The remaining clinical material enabled to 
perform miRNA sequencing for five of the eight ETP samples and both RPL samples (Supplementary Fig. S1e). 
Per sample, on average 21.7 million reads (range: 5.7–46.2 million) were produced with high mapping success to 
the human genome (mean: 95.6%; range: 88.8-98.8%). Of the mapped reads, mean 14.7% (range: 9.8-20.5%) were 
aligned to 732 mature microRNAs, generating the miRNA-Seq dataset investigated in the current study.
Underrepresentation of ncRNAs and histones in the placental transcriptome of RPL cases. The 
first principal component (PC1, 40.8% of variance) of the PCA across the placental transcriptomes of ETP (n = 8), 
RPL (n = 2) and normal gestations at term (Term norm, n = 8; dataset from14) separated clearly the 1st and 3rd 
trimester placental tissues (n = 14,767 analyzed transcripts; Fig. 1a). The same applies for the expression profile 
of placental protein encoding genes (n = 12,643; Fig. 1b) and miRNAs (n = 355; Fig. 1c), which appeared to be 
distinct for the early and late pregnancy (PC1 43.8% and 47.0% respectively). On the PCA plot, the transcrip-
tomes of the 1st trimester chorionic villi from the RPL and the ETP cases did not form clearly identifiable clusters. 
However, the microRNA profiles of RPL and ETP samples appeared to be separated by the second principal com-
ponent, representing 25.6% of overall variance (Fig. 1c).
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In the ETP placental samples, 13 of the 20 most highly expressed transcripts represented various small 
non-coding RNAs (ncRNAs), essential for the key nuclear and cellular functions such as pre-RNA and riboso-
mal RNA splicing (RNU4, RNU2 snRNA genes) and processing (SNORA and SNORD snoRNAs families), signal 
recognition particle RNAs involved in translation (7SL ncRNA family; Fig. 2a). Another class of prevalent tran-
scripts in the 1st trimester placental sample is responsible for the adequate secretion of placental hormones, e.g. 
CGA and CGB genes encoding for the alpha and beta-subunit of hCG, and KISS1 gene encoding kisspeptin. This 
transcriptome profile is consistent with our recently published data on term placentas14, where also the majority 
of the highly expressed genes encoded either regulatory ncRNAs or placental hormones (Fig. 2g). The profile 
of genes with the top expression level in the RPL placentas differed significantly from normal pregnancies for 
the proportion of ncRNAs (Fig. 2d; Supplementary Data S1). In the RPL samples only 23 of the 200 most highly 
expressed transcripts represent various ncRNAs compared to 60/200 for the ETP samples (Fisher’s exact test, 
P-value = 2.46 × 10−6). The top-200 most abundantly expressed genes in the RPL placentas miss completely the 
small nuclear genes RNU1–4, which are essential components of the spliceosome complex.
The placental transcriptome of the RPL and ETP cases differed also for highly expressed protein coding genes 
(Fig. 2b,e). In addition to the abundance of transcripts encoding placenta-specific hormones (CGA, CGB, KISS1, 
ADAM12, PSG3, CYP19A1), the chorionic villous tissue in the 1st trimester normal pregnancy was also character-
ized by high expression of histone encoding genes. Histones represented 36 of 200 genes with the highest expres-
sion level in the ETP samples compared to only one gene in the RPL samples (Fisher’s exact test, P-value = 0). As 
in term placentas the processes of cellular proliferation, replication and mitosis are slowed down, the proportional 
expression levels of histones and other basic components of the chromatin formation and nuclear machinery have 
dropped (Fig. 2h).
In contrast to the distinct set of the top-expressed genes in the RNA-Seq analysis, the majority of most abun-
dantly expressed microRNAs overlap between the chorionic villous samples from the ETP and RPL cases (17/20 
in the top list; Fig. 2c,f; Supplementary Data S2a). Interestingly, the top-20 lists in both ETP and RPL samples are 
enriched for microRNA, which belong to two placenta-specific imprinted miRNA clusters: paternally expressed 
ETP controls RPL cases Term norm
No of samples 8 2 8
Type of samples 1st trimester chorionic villi 1st trimester chorionic villi 3rd trimester placenta
Maternal age (years) 25.5 [18–33] 35.5 [32, 39] 33 [18–37]
Paternal age (years) 28.5 [20–47] 33 [30, 36] 34 [22–38]
Pre-pregnancy BMI (kg/m2) 22.2 [19.4–29.7] 20.3 [19.9, 20.6] 23.8 [17.4–30.0]
Nulliparity (n, %) 2 (25%) 1 (50%) 3 (38%)
Gravidity 2.5 [1–5] 7.5 [7, 8] 2 [1–5]
Previous pregnancy losses 0 5.5 [5, 6] 0 [0–1]
Previous ETP 1 [0–3] 0.5 [0, 1] 0 [0–1]
Gestational age at sampling (days) 60 [51–81] 55.5 [44, 67] 284 [268–291]
Fetal sex (female/male) 5/3 1/1 3/5
Newborn weight (g) N/A N/A 3756 [3102–4220]
Table 1.  Samples utilized for placental transcriptome sequencing and clinical characteristics of respective 
pregnancies. Data are given as median and range, except where indicated differently; nulliparity refers to 
no previous childbirth; gravidity refers to total number of experienced pregnancies. BMI, body mass index; 
ETP, elective termination of pregnancy; Term norm, placental samples representing uncomplicated normal 
pregnancy at term; RPL, recurrent pregnancy loss; n, number; N/A, not applicable.
Figure 1. Principal component analysis (PCA) of normalized read counts after variance stabilizing 
transformation in DESeq2. The first two principal components are plotted for (a) All genes (n = 14,767),  
(b) protein coding genes (n = 12,643) and (c) microRNAs (n = 335). Transcripts with mean read count < 50 
were excluded.
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C19MC (miR-512–3p, miR-515-5p, miR-516a-5p, miR-516b, miR-518b, miR-519c-3p) and maternally expressed 
C14MC (miR-127-3p)15. Among the top-100 microRNAs expressed in 1st trimester chorionic villi, more than 
one third (ETP: 38; RPL: 37 miRNAs) map to these placental microRNA clusters, evolved in primates (C19MC) 
or in mammals (C14MC, miR-371-3 cluster) (Supplementary Data S2b,c). The list of miRNAs with the highest 
placental expression overlaps between 1st trimester and term pregnancy placentas, although gestational dynamics 
of their transcript levels were observed (Fig. 2I; Supplementary Data S2d). In early pregnancy chorionic villi, 
miR-3182 was the highest expressed microRNA in both, the ETP and RPL groups. At term, the predominantly 
expressed microRNA was miR-143 exhibiting about 2-fold higher transcript level compared the next three 
top-expressed miRNAs (miR-181a, miR-26a, miR-22). The detected transcript levels of all other analyzed miRNAs 
were substantially lower. The placenta-specific miR-371-3 cluster was expressed highly in ETP and RPL, but its 
estimated expression level was reduced more than 4-fold at term.
Transcriptome profile in the RPL placentas reflects malfunction of basic nuclear processes and 
the organismal feedback mechanisms to rescue the fetus. Transcriptome of chorionic villi from the 
1st trimester RPL (n = 2) compared to ETP (n = 8) cases was characterized by a major shift in the expression levels 
of high number of genes (Fig. 3; Supplementary Data S3a). Differential expression of 189 genes matched the strin-
gent significance criteria applied in this study (false discovery rate (FDR) adjusted P < 0.1 for DESeq and P < 0.05 
for DESeq2; details in ‘Methods’; Supplementary Methods). Of these genes, 27% (n = 51) showed significantly 
higher and 73% (n = 138) lower transcript levels in RPL compared to ETP placentas. Notably, the functional cate-
gories of over- and under-expressed genes in RPL were distinct. Significantly upregulated loci are mostly protein 
encoding genes, which are involved in the protein processing/transport (n = 15; 29% of upregulated transcripts), 
fetal development (n = 6; 12%), cell adhesion, immune response and transcriptional regulation (n = 4; each 8%; 
Fig. 3a). Among them the genes ATF416,17, C318,19, PHLDA220, GPX421 and ICAM122 have been previously linked 
Figure 2. Expression levels of top 20 most abundant transcripts (a,d,g) logarithmic scale), protein-coding 
genes (b,e,h) linear scale) and microRNAs (c,f,i), linear scale; expressed in normalized read counts) in samples 
representing 1st trimester chorionic villi from normal (ETP, n = 8; (a,b) and recurrent pregnancy loss (RPL, 
n = 2; (d,e,f) placentas compared to normal term placentas (n = 8; (g,h,i). Annotation of placental transcripts 
detected and quantified by the RNA-Seq pipeline was based on ENSEMBL v67 database. Gene expression levels 
are expressed in FPKM (Fragments per kilobase of exon per million fragments mapped) as determined by 
cufflinks v 2.0.2; miRNA expression levels are given as DESeq2 normalized read counts. Data on the enrichment 
of gene expression in the placenta compared to other tissues was derived from Protein Atlas v12. Expression 
profile across tissues for noncoding RNAs was not available.
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with the pathogenesis of pregnancy loss. Additionally, GPX4 has been implicated in preeclampsia23, PHLDA224–26 
and SLC16A227,28 in fetal growth restriction, CD74 and LAPTM5 in preterm premature rupture of membranes29 
(details and full list of references in Supplementary Data S3b). Several short-listed genes function in trophoblast 
invasion, proliferation and syncytialization processes (EGR1, PDLIM1, MAPK3). In total, 13 of 51 genes exhibit-
ing increased expression in the RPL samples were supported by previous evidence for the involvement in placen-
tal function and/or pathology (Fig. 3a).
In contrast, the majority of genes exhibiting decreased expression represent various snRNAs/snoRNAs 
(n = 25; 18% of down-regulated transcripts), as well as ncRNAs involved in transcriptional, telomere, spliceosome 
and cellular protein traffic complexes (in total, n = 48; 35%) and components responsible for the basic cellular 
Figure 3. Genes with significantly (FDR adjusted P < 0.1 for DESeq and P < 0.05 for DESeq2; n = 189) 
altered expression levels in recurrent pregnancy loss (RPL, n = 2) compared to electively terminated 1st 
trimester pregnancies (ETP, n = 8). (a) Pie charts of functional categories of genes with elevated (n = 51, 
left) and reduced (n = 138, right) expression. (b) Heatmap with hierarchical clustering based on transformed 
read counts of the differentially expressed genes. Gene expression levels were subjected to variance stabilizing 
transformation in DESeq2 and standardized by subtracting the mean expression across all samples from 
its value for a given sample and then dividing by the standard deviation across all the samples. This scaled 
expression value, denoted as the row Z-score, is plotted in red-blue color scale with red indicating increased 
expression and blue indicating decreased expression. Hierarchical clustering of genes (rows) and samples 
(columns) was based on Pearson’s correlation. Hierarchical clustering trees are shown for the analyzed samples 
(top) and genes (left). For each sample newborn sex (M, male; F, female), and gestational age in days at sampling 
are given below the heatmap. Genes with prior evidence in the scientific literature for the involvement in 
placental function and pathology are highlighted on the right.
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apparatus for chromatin assembly (histone proteins, n = 29; 21%) and mitochondrial function (n = 7; 5%). These 
are critical processes to guarantee rapid proliferation and invasion of trophoblast in early pregnancy.
Differential expression analysis between the miRNA-Seq datasets of RPL (n = 2) and ETP (n = 5) samples 
identified no large disturbances in pregnancy loss samples (Supplementary Data S4). Among the microRNAs 
entering differential expression testing (n = 312), only miR-3168 showed statistically significant, ~ 8-fold ele-
vated transcript levels in RPL compared to ETP (DESeq: FDR adjusted P = 0.018; DESeq2: FDR P = 8.81 × 10−4). 
DESeq2 algorithm detected decreased and increased expression in RPL samples for additional 25 and 27 miRNAs, 
respectively. Several of these miRNAs have been shown to modulate the expression of tumor suppressor genes 
involved in proliferation and invasion (e.g. miR-1260b, miR-193a-3p, miR-494, miR-142-3p).
Concordant contribution of both RPL samples to differential expression outcome. As the sam-
ple size of our differential expression testing was small (RPL n = 2; ETP, n = 8), we assessed the robustness of its 
outcome by analysing the potential individual contribution of the two RPL samples. First, when we assessed the 
correlation of normalized gene expression read counts between the two RPL samples, the generated RNA-Seq 
(r2 = 0.92) and miRNA-Seq (r2 = 0.94) datasets showed high concordance (Supplementary Fig. S2). Next, we 
performed differential expression tests comparing the transcriptome of both RPL RNA-Seq datasets separately 
with the ETP group (Supplementary Data S5a,b). Gene expression levels for a very early miscarriage case RPL1 
(44 g.d.; female) differed significantly from the ETP samples (median gestational age 60 days) for as many as 483 
transcripts. The transcriptome of chorionic villi from the RPL2 case representing later gestational age (67 g.d., 
male) showed differential expression for 196 transcripts. Both separate lists of differentially expressed tran-
scripts included histone encoding genes (n = 48 and n = 46, respectively) and various ncRNAs (n =  69; n = 66) 
in the same abundance as the RPL vs ETP group comparisons. In the mutual comparison of the RPL1 and RPL2 
transcriptomes, 11 of the top 100 transcripts with largest difference in expression levels were sex-chromosomal 
genes referring to the different sex of the samples (Supplementary Data S5c). The remaining list of 89 transcripts 
included no histone genes, no ncRNA (except for a single lincRNA), no genes involved in mitochondrial func-
tion. Most probably, differences in measured gene expression levels between RPL1 and RPL2 reflect gestational 
dynamics in transcription regulation and stochastic differences between samples (statistical significance of these 
differences cannot be reliably estimated). In progression of pregnancy from 44 to 67 gestational days, 61/100 dif-
ferentially expressed genes showed increased expression and several of them encoded critical placental hormones 
(CSH1, GH2, PAPPA2, HSD11B2, LGALS14).
Confirmation of RNA-Seq results by Taqman RT-qPCR in an extended dataset. Validation of 
differential gene expression for selected genes was performed using Taqman RT-qPCR analysis in an extended 
placental sample-set (n = 14 RPL cases, 24 ETP controls; Supplementary Table S1 and S2). Statistically signif-
icant reduction in expression level in cases of RPL compared to ETP controls was robustly validated for the 
two analyzed histone-encoding genes, HIST1H1B and HIST1H4A (Wilcoxon test, fold change (fc) = 0.372, 
P = 1.97 × 10−4 and fc = 0.384, P = 9.37 × 10−4, respectively; Fig. 4). When the analysis was adjusted for gesta-
tional age, the statistical significance of differential expression between ETP and RPL samples level remains sta-
tistically significant (logistic regression, HIST1H1B: P = 4.8 × 10−3; HIST1H4A: P = 6.3 × 10−3).
Additionally, Taqman RT-qPCR analysis showed a trend for an increased expression of the Complement Component 
3 (C3) gene, concordant with the RNA-Seq dataset (fc = 3.57, P = 0.162; Supplementary Fig. S3). However, this out-
come did not reach statistical significance possibly due to differences in the study material composition (RNA-Seq: 
microdissected chorionic villi; Taqman RT-qPCR: placental samples comprised of variable cell types). The validation 
experiments did not confirm increased expression of CAPNS1 and PLTP in extended RPL placental tissues.
Figure 4. Significantly decreased expression of HIST1H1B and HIST1H4A in placental tissue from the 
cases of recurrent pregnancy loss (RPL, n = 14) compared to uncomplicated, but electively terminated 
pregnancies (ETP, n = 24). Placental gene expression levels were measured using Taqman RT-qPCR 
(HIST1H1B assay ID: Hs00271207_s1; HIST1H4A assay ID: Hs00747492_s1). The median expression level of 
the ETP group was selected as a calibrator and the respective relative mRNA expression levels are shown on 
logarithmic scale. Dots represent data of each patient; the bars denote median and the 25th and 75th percentiles. 
Fold change (fc) was calculated as the difference of mean relative expression value of RPL versus ETP group;  
P-values were estimated by Wilcoxon test.
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Limited effect of maternal age on placental gene expression in the first trimester ETP samples. 
As the average maternal age of the RPL samples (mean: 35.5; median: 35.5; range: 32–39 years) was higher com-
pared to the ETP controls (mean: 25.5; median 25.5; range: 18–33), we investigated a potential confounding effect 
of the maternal age on placental gene expression in early pregnancy. Differential expression was tested between the 
ETP subgroups representing young (18, 19, 21 and 24 years) and early middle-aged women (27, 30, 32 and 33 years). 
No genes corresponded to the robust differential expression criteria applied in the current study (FDR P < 0.1 for 
DESeq and P < 0.05 for DESeq2). In the analysis using DESeq programme, none of the tests reached FDR levels 
below one (Supplementary Data S6). Differential expression testing implemented in DESeq2 highlighted two 
genes: KEL (FDR P = 5.40 × 10−4) and POF1B (FDR P = 1.24 × 10−3) (Fig. 5; Supplementary Data S6). Both genes 
exhibit low to moderate placental expression (mean read counts < 200) and no previous studies have assessed 
their expression in the human placenta. The KEL gene encodes the KELL blood group antigen (OMIM: #110900) 
and exhibited reduced expression in older mothers and RPL patients (Fig. 5a). POF1B (Premature ova-rian 
failure protein 1) is mostly expressed in epithelia and specifically in skin epidermis30 and low transcript levels 
have been also detected in female reproductive tissues, cervix, fallopian tube, placenta31,32. Mutations in POF1B 
have been associated with premature ovarian failure33. In chorionic villous samples, POF1B exhibited elevated 
expression in older ETP mothers, but not in mothers with RPL (Fig. 5b). Based on these findings, supported by 
our previous RNA-Seq study in 40 term placentas14, we conclude that a confounding effect of maternal age on 
placental gene expression, if present, is limited.
Figure 5. Maternal age dependent differential expression in the placenta representing uncomplicated 
early pregnancy (ETP group, n = 8) was detected for only two genes (KEL, POF1B; DESeq2: FDR P < 0.05; 
Supplementary Data S6). (a) KEL (Kell blood group, metallo-endopeptidase) and (b) POF1B (Premature ovarian 
failure protein 1B) gene expression levels are presented as normalized read counts for individual chorionic 
villous samples in the ETP (left) and RPL (right) groups. Maternal ages in years are given for each analysed 
sample. ETP, electively terminated pregnancy; RPL, recurrent pregnancy loss.
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Potential key role of E2F transcription factor family in triggering the fetal programming 
towards pregnancy loss. To further functionally characterize the biological pathways involved in altered 
transcriptome profile in the RPL compared to the ETP placentas, we performed gene set enrichment analysis for 
the list of differentially expressed genes. As expected, among the down-regulated genes an extreme enrichment 
for functional categories including histones was observed, such as ‘Nucleosome’ (GO:0000786; P  = 2.34 × 10−53; 
32.1% of the genes in the category), ‘Nucleosome assembly’ (GO:0006334; P = 3.27 × 10−34; 18.8%) and his-
tone H4-K20 demethylation (GO:0035574; P  = 6.46 × 10−10; 43.8%) (Table 2; Supplementary Data S7). Genes 
involved in a large pathway ‘Extracellular region’ (GO:0005576; P  = 7.36 × 10−14) represent 2/3 of the full list 
of independent annotated genes entering the functional profiling analysis. Whereas the list of transcripts in this 
category with decreased expression is comprised of histones and loci involved in mitochondrial function, the 
list of transcripts with increased expression level are encoded by several genes previously implicated in placental 
function, pregnancy loss and/or complications, such as CD74, ICAM1, PLTP, MAPK3, C3, GPX4.
Importantly, a few transcription factors (TF) emerged as potential key players in programming the tropho-
blastic genome and cells towards discontinuation of the pregnancy. Notably, 11 of 15 TF-binding sequence motifs, 
which were enriched in the promoter regions of differentially expressed genes in RPL chorionic villous sam-
ples, represented binding sites for various E2F TF family members or E2F:DP-1 heterodimer complexes (Table 2; 
Supplementary Data S7). The most significant enrichment was detected for the E2F motif ‘NCSCGCSAAAN’ 
(TF:M00919_1; P = 5.31 × 10−6; 3% of pathway genes; 14.7% of query genes). The largest fraction of genes with 
either increased or decreased transcript levels carried the binding sites for E2F-1 (motif ‘NKTSSCGC’, 60.8% of 
genes; P = 1.47 × 10−3) and/or for the TF-complex Rb:E2F-1:DP-1 (motif ‘TTTSGCGC’, 34.3%, P = 1.26 × 10−3). 
The E2F recognition sites are found in the promoters of genes involved in cell cycle or DNA replication and a 
specific role of E2F has been demonstrated in regulating mammalian endocycle, yielding in highly polyploid cells 
such as placental syncytiotrophoblasts34. A recent study showed that placental transcriptional network is tightly 
coordinated by activation and repression through the two distinct arms of the E2F TF-family and this mechanism 
has direct implications for extra-embryonic cell proliferation, placental development and fetal viability35.
Discussion
Recurrent pregnancy loss (RPL) represents an insufficiently acknowledged common disease without adequate 
management options. Research on the causes and mechanisms of RPL represent a challenge, as it is a complex 
disorder involving both partners and their miscarried pregnancies36. There are worldwide increasing trends in the 
prevalence of RPL due to growing age of couples aiming at childbirth, as well as availability of assisted reproduc-
tive technologies (ART), such as in vitro fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI). In the 
current study we sought to determine the placental differential gene expression signature associated with RPL and 
bring novel insights into the involved biological pathways with the ultimate aim to identify potential candidates 
for the development of therapies for this complex disorder.
As the first main outcome we report novel molecular mechanisms behind directing a pregnancy towards a 
miscarriage scenario. Our data suggests that this scenario is programmed initially at the genomic level through 
winding down DNA replication, chromatin assembly, RNA processing machinery and basic cellular metabolic 
function – all key processes to guarantee rapid proliferation of trophoblastic cells essential for placental formation 
and invasion to establish a viable pregnancy. Chorionic villous samples from RPL cases compared to electively 
terminated, but uncomplicated pregnancies (ETP) had substantially decreased transcript levels of histones, reg-
ulatory RNAs (snRNA, snoRNAs) and genes involved in telomere, spliceosome, ribosomal and mitochondrial 
and intra-cellular signaling functions (Fig. 2a,b,d,e; Fig. 3; Supplementary Data S3). Notably, no such system-
atic differential expression was detected for the microRNA transcript profile between the RPL and ETP samples 
(Fig. 2c,f; Supplementary Data S4).
As an important novel insight, the data points to E2F transcription factor (TF) family as a molecular mech-
anism to trigger the coordinated process in programming the fetal genome to gradually stop the maintenance 
of basic nuclear and cellular functions. Transcriptional activity of the majority of differentially expressed 
genes in RPL placentas was predicted to be regulated by E2F TFs or E2F:DP1 heterodimer complexes (Table 2; 
Supplementary Data S7). In mammals, E2F family is exclusively involved in cell cycle regulation and DNA syn-
thesis, controlling cell-cycle progression from G1 to S phase via the coordinated action activators (E2F1-E2F3) 
and repressors (e.g. E2F7-E2F8). A specific crucial role of E2F transcription factors has been shown in orches-
trating endocycle in mammalian cells – genome replication in the absence of cell division34. This is a key feature 
in implantation process and normally functioning trophoblastic cells, and is represented in the most extreme 
form in multinuclear syncytiotrophoblast layer in the human placenta and in trophoblastic giant cells in mouse37. 
Consistent with the critical role of endocycle process in the normal placental development and function, our 
recent study identified an extensive load of somatic structural variants in the human placental genome and the 
highest fraction of genomic rearrangements was detected in normal pregnancies38. Endoreplication is essential 
for normal early development in many eukaryotic organisms39 and the role of E2F transcription factors in the 
involved processes appears to be evolutionarily conserved among mammals and insects40.
In mammals, E2F transcription factors have a key role in coordinating the placental transcriptional net-
work to guarantee proper cellular proliferation, placental development and ultimately, fetal viability35,41. Murine 
E2f7− /− and E2f8− /− embryos exhibited a severely compromised placenta associated with ectopic proliferation, 
apoptosis, and altered differentiation of extra-embryonic cell lineages and embryonic death by E11.535,42. The 
loss of Dp1 – acting in unison with E2F forming functional heterodimers, leads to death in utero due to failed 
extra-embryonic development represented by compromised expansion of the ectoplacental cone and chorion, 
and impaired endoreduplication in trophoblast giant cells43. Our data are also consistent with studies, which have 
implicated E2F transcription factors in regulating the expression of mitochondria-associated genes44,45. This novel 
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function of E2F factors together with the crucial role in cell cycle has been suggested to have a major impact on 
cell viability, independent of induction of apoptotic genes.
Importantly, the E2F transcription factor family plays also a critical role in controlling tumor progression, 
angiogenesis and metastasis in cancer46–48. In perspective, knowledge on the mechanisms leading to failed pro-
liferation and invasion of trophoblastic cells and impaired placental development may also have implications to 
cancer biology and therapeutic solutions.
Seminal microarray-based investigations of transcriptome and proteome of chorionic villi from RPL patients 
have demonstrated a dysregulated (mostly increased) expression of genes involved in regulating of immune 
function, apoptosis, angiogenesis and cytotrophoblast invasion11,12,49–51. All these processes are also represented 
among the upregulated genes in our dataset (Fig. 3A; details and references in Supplementary Data S3). As an 
important result, our data provided support for the involvement of several previously suggested genes linked to 
adverse pregnancy outcomes and/or placental function. Among 51 loci with significantly increased transcript 
levels there were five genes with independent literature evidence for involvement in RPL (C3, PHLDA2, ATF4, 
Significantly overrepresented functional categories 1Enrichment analysis Gene expression levels in RPL compared to ETP
type ID Name
Pathway 
genes (%)
Query 
genes (%)
Corrected 
P-value Increased Decreased
A. Gene Ontology (GO)
 CC 0000786 nucleosome 32.1 41.0 2.34 × 10−53 none histones (n = 34)
 BP 0006334 nucleosome assembly 18.8 32.5 3.27 × 10−34 none histones (n = 27)
 MF 0046982 protein heterodimerization activity 6.4 37.3 5.07 × 10
−25 ATF4 histones (n = 31)
 CC 0005576 extracellular region 1.2 67.5 7.36 × 10−14
CD74, CTSA, FTL,
ICAM1, PLTP, MAPK3, PPP2CB, CDC37, 
SYNGR2, MDK, RAB35, C3, CAPNS1, NBL1, 
FRZB, GPX4, LRG1, FAM20C, LAMB3
histones (n = 31)
Mitochondrial function: 
MT-RNR2, MTRNR2L9, 
MTRNR2L8, MTRNR2L10, 
MTRNR2L3, MTRNR2L1
 BP 0035574 histone H4-K20 demethylation 43.8 8.4 6.46 × 10−10 none histones (n = 7)
 MF 0003677 DNA binding 1.5 45.8 6.92 × 10−10 EGR1, ZFP36, ATF4, WBP2 histones (n = 34)
 BP 0006303 double-strand break repair via non-homologous end joining 10.4 8.4 4.11 × 10
−5 none histones (n = 7)
 BP 0007264 small GTPase mediated signal transduction 1.9 21.7 2.29 × 10
−4 MAPK3, PPP2CB, RAB35, ARL4C histones (n = 14)
B. TRANScription database (TRANSFAC)
 tf M00919_1 E2F; motif: NCSCGCSAAAN 3 14.7 5.31 × 10−6 CAPNS1, WBP2, ARL4C histones (n= 12)
 tf M00516_0 E2F; motif: TTTSGCGCGMNR 3.1 13.7 1.33 × 10−5 ARL4C histones (n = 13)
 tf M00939_1 E2F; motif: TTTSGCGSG 2.6 14.7 3.34 × 10−5 CAPNS1, WBP2, ARL4C histones (n = 12)
 tf M00918_1 E2F; motif: TTTSGCGSG 2.8 12.7 1.18 × 10−4 CAPNS1, WBP2, ARL4C histones (n = 10)
 tf M00738_0 E2F-4: DP-1; motif: TTTSGCGC 1.1 30.4 4.01 × 10
−4
CDC37, PDLIM1,
ZFP36, WBP2, TMUB1,
ARL4C
histones (n = 11)
SNORA-s (n = 4)
RNU genes (n= 2)
HNRPA0, RN7SK
 tf M00920_1 E2F; motif: NKCGCGCSAAAN 2.4 12.7 8.39 × 10−4 WBP2, ARL4C histones (n = 11)
 tf M00209_0 NF-Y; motif: NCTGATTGGYTASY 1.5 20.6 9.53 × 10
−4 PI4K2A, C1ORF122 histones (n = 18), SNORA38B
 tf M00210_0 OCT-x; motif: CTNATTTGCATAY 1.3 22.5 9.53 × 10
−4 EGR1 histones (n = 19)RNU genes (n = 3)
 tf M00740_0 Rb:E2F-1:DP-1; motif: TTTSGCGC 1 34.3 1.26 × 10
−3
CDC37, PDLIM1,
ZFP36, WBP2, ARL4C,
TMUB1
histones (n = 20)
SNORA-s (n = 4)
RNU genes (n = 2)
HNRPA0, RN7SK, 
MTRNR2L10
 tf M00428_0 E2F-1; motif: NKTSSCGC 0.7 60.8 1.47 × 10−3
CD74, CTSA, ICAM1,
PDLIM1, SYNGR2, MDK, RAB35, EGR1, PIGT,
ZFP36, ATF4, NINJ1,
WBP2, SLC16A2,
PI4K2A, TMUB1, GPX4,
PRELID1, FAM20C, GRINA, PHLDA2, ARL4C
histones (n = 30)
SNORA-s (n = 2)  
RNU genes (n = 4)
HNRPA0, SCARNA5,
SSTR5-AS1,
MTRNR2L10
Table 2.  Overrepresented functional categories among the differentially expressed genes in placental 
chorionic villi in RPL compared to ETP samples. 1Gene enrichment analysis was implemented in g:Profiler 
software65. The query included differentially expressed genes from Supplementary Data S3, which were 
annotated in ENSEMBL. The analysis used a conservative output function ‘Best per parent group (strong)’. 
Overrepresented functional categories in GO and TRANSFAC databases with highly significant statistical 
support are shown (P < 1 × 10–2). Full analysis details and gene enrichment profiling for the REACtome 
categories are provided in Supplementary Data S7. Query to miRBase database did not result in any statistically 
significant outcome. BP, Biological Process; CC, Cellular Component; ETP, electively terminated pregnancy 
with no gestational complications; MF, Molecular Function; RPL, recurrent pregnancy loss; tf, transcription 
factor binding motif.
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ICAM1, GPX4). Additional 8 genes are associated with pregnancy complications or placental function (Fig. 3B). 
Some of these genes are dysregulated in multiple adverse pregnancy complications, such as imprinted and mater-
nally expressed gene PHLDA2, which is linked to RPL, fetal growth restriction (FGR) and preeclampsia20,24–26. 
A number of pregnancy complications including RPL, FGR, hypertensive disorders in pregnancy and preterm 
birth are associated with excessive or misdirected complement activation, where C3 has a distinct role in early 
pregnancy18.
To our knowledge, this is the first study using RNA-Seq to profiling of the transcriptome and miRNome of 
chorionic villi representing RPL cases in comparison with uncomplicated early pregnancy. Choice of RNA-Seq 
using ribo-depleted (not polyA-enriched) total RNA for library preparation enabled interrogation of the full pro-
file of placental transcriptome including ncRNAs and histone genes, which are typically not represented on com-
mercial microarrays. As a limitation in our study, the replication experiments differed from the discovery study in 
initial preparation of samples. For the discovery RNA-Seq and miRNA-Seq experiments we used chorionic villi, 
which were dissected under stereomicroscope in a specialized laboratory and karyotyped to exclude any gross 
chromosomal aberration (RPL, n = 2; ETP n = 8). Chorionic villous samples used only in the TaqMan RT-qPCR 
experiment (RPL, n = 12; ETP, n = 16) were dissected in the delivery room and the karyotype of the fetus was ana-
lysed only for some cases. Thus, the placental samples used in the replication experiments may have occasionally 
included also maternal decidual cells or represent pregnancies with chromosomal anomalies. Despite this limita-
tion, Taqman RT-qPCR replication experiments confirmed a substantial decrease in the expression of HIST1H1B 
and HIST1A4H genes (encoding histone 1 and histone 4) in the RPL samples.
We acknowledge that any molecular studies targeting the causes and mechanisms of recurrent pregnancy loss 
in humans have their limits in terms of sample size and data interpretation, which are already predefined by the 
complexity of this disorder. The nature of miscarriage process does not allow to design a study capable to distin-
guish properly, whether the reported altered pathways represent underlying mechanisms causing or triggering 
pregnancy loss or merely accompanying consequences to the already ‘programmed’ miscarriage scenario. Thus, 
it is not possible to ultimately exclude that the findings of the current study reflect the processes associated with 
fetal demise. However, in the latter case we would expect the observed changes to appear prominently on the 
principal component analysis and be less specific to certain biological pathways.
Conclusions
The compiled evidence suggests that early pregnancy losses may be triggered and/or mediated by decreased func-
tional capacity of the placental genome. The chorionic villous samples from recurrent pregnancy loss (RPL) cases 
compared to normal 1st trimester pregnancy had substantially reduced transcript levels of proteins and ncRNAs 
involved in chromatin assembly, RNA processing, mitochondrial function and other components of the basic 
nuclear and cellular machinery. We expect that these mechanisms are not unique to RPL cases, but similar pro-
cesses may accompany sporadic pregnancy loss events. The early placenta is characterized by extremely rapid 
development and growth, proliferation and invasion of trophoblastic cells that require high and constant supply 
of all these molecules in order to establish a viable pregnancy.
The current study detected for the first time that majority of the differentially expressed genes in chorionic villi 
of RPL cases are regulated by E2F family of transcription factors and their functional partner DP1, both known 
to be involved in endoreplication and placental development. This favors the scenario that pregnancy loss is pro-
grammed as a cascade of events, which coordinately directs the developing placenta towards shutting down all the 
basic nuclear and cellular functions, and finally leading to miscarriage. The role of E2F/DP1 transcription factors 
and linked pathways in orchestrating this cascade of events needs further investigations not only from the basic 
research angle, but also as a potential source to identify therapeutic targets for RPL.
The study detected differential expression of a number of genes previously reported in connection with 
adverse pregnancy outcomes and/or placental function, including five genes implicated in RPL (C3, PHLDA2, 
ATF4, ICAM1, GPX4). The list of differentially expressed genes in RPL represents a source for generating mouse 
models to investigate in vivo treatment options for RPL, for screening genetic variants predisposing to pregnancy 
failure and for developing biomarkers for monitoring of early pregnancies in clinical risk cases (e.g. pregnancies 
achieved through ART).
Methods
Ethics statement. The study was approved by the Ethics Review Committee of Human Research of the 
University of Tartu, Estonia (permissions no 117/9, 16.06.2003; 146/18, 27.02.2006; 150/33, 19.06.2006; 212/M-
32, 09.03.2012) and it was carried out in compliance with the Helsinki Declaration. A written informed consent 
to participate in the study was obtained from each individual prior to recruitment. All study participants were 
recruited and the study material was collected at the Women’s Clinic of Tartu University Hospital, Estonia in 
2003–2012. All participants were of white European ancestry and living in Estonia. All methods were carried out 
in accordance with approved guidelines.
Study patients and placental samples of RPL and ETP groups. Recurrent pregnancy loss (RPL) 
patients analyzed in the current study (in total n = 14; maternal age 32.9 ± 4.6 years, gestational age 58.9 ± 17.3 
days) had experienced at least two consecutive miscarriage events before this case. The following known strong 
risk factors of pregnancy loss had been excluded: abnormal menstrual cycle, genital infections, antiphospholipid 
syndrome, thrombophilic mutations in female partner and abnormal karyotype of both partners of the RPL 
couples (details in Supplementary Methods). The two women with the index RPL pregnancies, allocated to 
RNA-Seq/miRNA-Seq analysis of chorionic villi, had experienced five (RPL1) and six (RPL2) clinically confirmed 
pregnancy losses before the index case. The RPL placental samples were collected at surgical removal of conceptus 
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shortly (within 24 hours) after detection of fetal death. In both cases, the most recent ultrasound scan confirming 
the heart beats and normal growth of the fetus had been performed five (RPL1) and seven (RPL2) days before the 
event. Gestational age in used the study for RPL cases was based on the measurement of crown-rump-length of 
the fetus.
The patients in ‘elective termination of pregnancy’ group (ETP; in total n = 32) had experienced normal 1st 
trimester pregnancies with no maternal or fetal clinical complications until the termination of the pregnancy 
(maternal age 26.8 ± 6.2 years, gestational age 64.5 ± 13.2 days). None of the patients had experienced any clini-
cally confirmed pregnancy losses in their reproductive history.
For the RNA-Seq/miRNA-Seq profiling, the tissue samples were obtained immediately after surgical ter-
mination of pregnancy (ETP group, n = 8) or surgical removal of conceptus (RPL group; n = 2) under general 
anaesthesia (Table 1). The maternal tissue was removed under a stereomicroscope (Discovery V8, Zeiss) and cho-
rionic villi containing both cyto- and syncytiotrophoblast cells were placed into RNAlater solution (Ambion Inc, 
Life Technologies) and stored at − 80 °C without any further manipulation. For all samples entering RNA-Seq/
miRNA-Seq, part of the purified trophoblast cell population was karyotyped and it confirmed normal male or 
female karyotype in all cases (United Laboratories, Tartu University Hospital). Both RPL samples were subjected 
in parallel to RNA-Seq and miRNA-Seq dataset generation, whereas for the ETP samples the remaining clinical 
material after RNA-Seq experiment enabled to perform miRNA-Seq for 5/8 ETP samples.
Taqman RT-qPCR validation experiments included an extended placental sampleset from the ETP (n = 24) 
and RPL (n = 12) groups (Supplementary Table S1). These placental samples had not been subjected to dissection 
of chorionic villi under microscope. After washing in PBS to remove blood, chorionic villi were separated visually, 
followed by snap-freezing in liquid nitrogen or placing into RNAlater solution. Samples were kept at − 80 °C until 
RNA isolation52 (details in Supplementary Methods).
RNA-Seq and miRNA-Seq. Total RNA was extracted from 200–300 mg of homogenized placental tissue 
using TRIzol reagent (Invitrogen, Life Technologies). RNA intergrity number (RIN) values for the two RPL sam-
ples were 7.8 and 7.9 and for the eight ETP samples ranged from 6.2 to 8.9 (median 7.9).
To produce RNA-Seq libraries total RNA was further purified with RNeasy MinElute columns (Qiagen, 
Netherlands) according to the manufacturers’ protocol. High quality DNA-free total RNA (5 μ g) was used for 
rRNA depletion (Ribo-Zero™ rRNA Removal Kit, Epicentre) and library preparation with cDNA synthesis (Life 
Technologies) followed by Nextera™ Technology (Illumina). For miRNA-Seq, initial small-RNA libraries were 
prepared from 1 μ g total RNA (TruSeq Small RNA kit, Illumina), followed by microRNA enrichment (Caliper 
LabChipXT, PerkinElmer) according to manufacturer’s protocols. RNA-Seq (46 bp paired end reads for ETP sam-
ples; for RPL samples 101 bp paired end reads were trimmed to 50 bp) and miRNA-Seq libraries were sequenced 
on Illumina HiSeq 2000.
Initial RNA-Seq data analysis and preparation was conducted by the RNA-Seq pipeline v2.4 (Sequencing 
Unit, FIMM Technology Centre) consisting of FastQC version 0.10.0 for quality control; reads were filtered for 
adaptor, rRNA and mtDNA sequences as well as homopolymer stretches using custom python scripts. Reads were 
aligned to human genome assembly (GRCh37.p7/hg19) with TopHat version 2.0.353. Transcript quantification 
was conducted with Cufflinks v 2.0.254 with reference annotation (measured as FPKM) and gene expression was 
quantified by htseq-count55 (as raw read counts). Further details of library preparation, RNA-Seq and basic bio-
informatics of raw data is provided in14.
Initial analysis of microRNA sequencing data included removal of the 3′ adaptor sequence and discarding 
reads with the trimmed length < 14 bp. Reads were mapped with bowtie (v0.12.7)56 to the reference genome 
(GRCh37.p7/hg19) allowing a maximum of 1 mismatch. Calculation of the raw read counts was performed using 
a modified version of Emir57 bioinformatic pipeline using mature miRNA expression database (mirBASE v18).
RNA-Seq dataset for term placental samples from normal pregnancy. The RNA-Seq dataset rep-
resenting term placental transcriptome in normal, uncomplicated pregnancies (group ‘Term norm’) was derived 
from previous published report14 and utilized as a reference to compare with the 1st trimester placental gene 
expression (see Supplementary Methods).
Taqman RT-qPCR. Five genes were selected for confirmation of differential expression using Taqman 
RT-qPCR method and in an independent sample-set. The inclusion criteria were genes with high fold change 
(> 4), substantial placental gene expression (> 150 normalized read count) and commercially available assays 
from Applied Biosystems (Life Technologies; Supplementary Table S2). Among the down-regulated genes we 
selected for validation experiments HIST1H1B (encoding histone H1) and HIST1H4A (histone H4), and among 
the upregulated gene-list C3 (complement component 3), CAPNS1 (calpain, small subunit 1) and PLTP (phos-
pholipid transfer protein). Among these, C3 and PLTP have also literature evidence for the involvement of RPL 
and/or function at the feto-maternal interface18,58,59. For CAPNS1 a role in acute allograft rejection has been 
reported60.
Gene expression was quantitated by biplex RT-qPCR of the target gene and housekeeping gene YHWAZ 
sequence using pre-made TaqMan Gene Expression Assays (Hs03044281_g1, Applied Biosystems, Life 
Technologies). YHWAZ was selected as the most stable ready-to-use housekeeping gene based on data from RNA 
sequencing and literature sources61. cDNA was synthesized from 1 μ g total RNA according to the manufacturer’s 
instructions (SuperScript III Reverse Transcriptase, Life Technologies). All qPCR reactions were performed in 
triplicate in 384 micro-well plates in ABI 7900HT Real-time PCR system (Applied Biosystems, Life Technologies) 
using HOT FIREPol® Probe qPCR Mix (Solis BioDyne, Tartu, Estonia). Full experimental details of the Taqman 
RT-qPCR are provided in Supplementary Methods.
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Statistical analysis. Differential expression in RNA-Seq and miRNA-Seq data was tested using DESeq62 and 
DESeq263 packages for R64. Read counts from htseq-count (for RNA-Seq) and Emir pipeline (for miRNA-Seq) 
were used as input and built-in normalization algorithms of DESeq and DESeq2 were used. Outlier detection 
and handling was performed using the default method in DESeq. In DESeq2 outliers were replaced using the 
replaceOutliersWithTrimmedMean function with default Cook’s distance cutoff. In the current study a gene was 
considered as differentially expressed, when the statistical tests simultaneously satisfied the following thresholds: 
FDR adjusted P < 0.1 for DESeq and FDR adjusted P < 0.05 for DESeq2. In RNA-Seq and miRNA-Seq datasets, 
genes with mean normalized expression < 50 reads in all samples (n = 39,109 RNA-Seq; n = 555 miRNA-Seq) 
were considered transcriptional noise and filtered out from the analysis. Statistical testing, principal component 
analysis (PCA) and hierarchical clustering (Pearson correlation as the distance function) were performed in R.
Gene set enrichment analysis for the differentially expressed genes in RPL (n = 2) compared to ETP (n = 8) 
chorionic villous samples was performed using g:Profiler65. Enrichment was tested for the functional categories 
defined in Gene Ontology (GO), Reactome (REAC) databases, as well as for the transcription binding site motifs 
from TRANSFAC database and miRBase microRNAs. Functional profiling applied the default input option 
‘Only annotated genes’ (n = 83 independent genes from Supplementary Data S3) and selected output option 
‘Best per parent group (strong)’. The analysis criteria to claim statistical significance applied g:SCS threshold 
as recommended by the software developer. g:SCS threshold is a value pre-calculated for query list sizes up to 
1000 genes. The algorithm considers the set structure underlying gene sets annotated to terms of each organ-
ism, and should therefore give a tighter threshold to significant results compared to Bonferroni correction or 
Benjamini-Hochberg FDR.
Statistical analyses for Taqman RT-qPCR results were performed using statistical package STATA version 13.1. 
Significance of RT-qPCR measurements among the study groups was assessed by Wilcoxon test (no covariates) 
and logistic regression (gestational age as covariate). Results with nominal P-values P < 0.01 were considered as 
significant. Additional details of the statistical analysis are provided in Supplementary Methods.
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